Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison

scientific article published on May 2011

Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4088/JCP.10M06743
P698PubMed publication ID21658349

P50authorConrad P EarnestQ37378215
Steven BlairQ61196520
Madhukar TrivediQ87600331
Timothy S ChurchQ96143449
P2093author name stringBruce D Grannemann
Daniel I Galper
Steven S Henley
Andrea L Dunn
Thomas J Carmody
Tracy L Greer
Prabha Sunderajan
P433issue5
P921main subjectmajor depressive disorderQ42844
P304page(s)677-684
P577publication date2011-05-01
P1433published inThe Journal of Clinical PsychiatryQ7743563
P1476titleExercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison
P478volume72

Reverse relations

cites work (P2860)
Q30383857A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression.
Q36387054A pilot study of women's affective responses to common and uncommon forms of aerobic exercise
Q36288038A preliminary, randomized trial of aerobic exercise for alcohol dependence
Q36743908Aerobic Exercise for Reducing Migraine Burden: Mechanisms, Markers, and Models of Change Processes
Q38388409Affect Following First Exercise Session as a Predictor of Treatment Response in Depression
Q34791332Association between physical activity and depressive symptoms: midlife women in SWAN.
Q61440471Association between physical exercise and mental health in 1·2 million individuals in the USA between 2011 and 2015: a cross-sectional study
Q42158020Atypical depressive symptoms as a predictor of treatment response to exercise in Major Depressive Disorder
Q26782997Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics
Q39328768Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression
Q34464962DEMO-II trial. Aerobic exercise versus stretching exercise in patients with major depression-a randomised clinical trial
Q37712388Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder
Q26785999Depression and Exercise: A Clinical Review and Management Guideline
Q50531989Depressive Symptom Dimensions and Their Association with Hippocampal and Entorhinal Cortex Volumes in Community Dwelling Older Adults.
Q46674667Does exercise improve self-reported sleep quality in non-remitted major depressive disorder?
Q55364555Effects of a 12-week running programme in youth and adults with complex mood disorders.
Q37345200Effects of creatine monohydrate supplementation and exercise on depression-like behaviors and raphe 5-HT neurons in mice
Q41086751Evaluation of anhedonia with the Snaith-Hamilton Pleasure Scale (SHAPS) in adult outpatients with major depressive disorder
Q30382252Exercise Augmentation of Exposure Therapy for PTSD: Rationale and Pilot Efficacy Data
Q36243437Exercise as an adjunct treatment for opiate agonist treatment: review of the current research and implementation strategies
Q48012950Exercise augmentation compared with usual care for post-traumatic stress disorder: a randomized controlled trial.
Q24198097Exercise for depression
Q38092181Exercise in the treatment of major depression: a systematic review grading the quality of evidence
Q47364349Exercise is an effective treatment for positive valence symptoms in major depression
Q38664894Exercise training - A beneficial intervention in the treatment of alcohol use disorders?
Q36043319IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder.
Q39778779IMPROVEMENTS IN PSYCHOSOCIAL FUNCTIONING AND HEALTH-RELATED QUALITY OF LIFE FOLLOWING EXERCISE AUGMENTATION IN PATIENTS WITH TREATMENT RESPONSE BUT NONREMITTED MAJOR DEPRESSIVE DISORDER: RESULTS FROM THE TREAD STUDY.
Q47694934Immune-based strategies for mood disorders: facts and challenges
Q41173157Immunological effects of behavioral activation with exercise in major depression: an exploratory randomized controlled trial
Q26745562Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology
Q37310533Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment.
Q34493536Inflammation: depression fans the flames and feasts on the heat
Q36733303Is Exercise an Efficacious Treatment for Depression? A Comment upon Recent Negative Findings
Q39292984Jogging Therapy for Hikikomori Social Withdrawal and Increased Cerebral Hemodynamics: A Case Report
Q47793403Long-term effects of exercise at different intensity levels on depression: A randomized controlled trial
Q34511957MAP training: combining meditation and aerobic exercise reduces depression and rumination while enhancing synchronized brain activity
Q37981491Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments
Q35984653Optimizing the Exercise Prescription for Depression: The Search for Biomarkers of Response
Q47556460Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation
Q37136799Physical activity in depressed elderly. A systematic review.
Q30217599Physical activity patterns among U.S. adults with and without serious psychological distress
Q36100305Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.
Q64067030Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED Trials
Q47838168Prediction of treatment outcomes to exercise in patients with nonremitted major depressive disorder.
Q41020780Predictors of depression outcomes among abstinent methamphetamine-dependent individuals exposed to an exercise intervention
Q41703239Predictors of depression outcomes among abstinent methamphetamine-dependent individuals exposed to an exercise intervention
Q36438114Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder
Q34427065Rationale for Using Exercise in the Treatment of Stimulant Use Disorders
Q44771340Re: a new discussion for "The projected effect of increasing physical activity on reducing the prevalence of common mental disorders among Canadian men and women: a national population-based community study".
Q34067359Role of the dorsal medial habenula in the regulation of voluntary activity, motor function, hedonic state, and primary reinforcement
Q36827478STimulant Reduction Intervention using Dosed Exercise (STRIDE) - Description of the Exercise Intervention and Behavioral Program to Ensure Adherence
Q36246443Sedentary behavior and physical activity are independent predictors of successful aging in middle-aged and older adults
Q38569937The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder
Q36524243The pro-inflammatory profile of depressed patients is (partly) related to obesity
Q39510397The projected effect of increasing physical activity on reducing the prevalence of common mental disorders among Canadian men and women: a national population-based community study
Q38543238Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder
Q40626205Training fast or slow? Exercise for depression: A randomized controlled trial
Q36583311Treating depression and depression-like behavior with physical activity: an immune perspective
Q47601841Treating depression with physical activity in adolescents and young adults: a systematic review and meta-analysis of randomised controlled trials
Q38300376Understanding the role of adjunctive nonpharmacological therapies in management of the multiple pathways to depression

Search more.